Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database

References

• World Health Organization. Atlas of headache disorders and resources in the world 2011. 2011; [cited 2020 Aug 26]. Available from: https://www.who.int/mental_health/management/atlas_headache_disorders/en/.
   Google Scholar
• Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.
   PubMed Web of Science ®Google Scholar
• Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–315.
   PubMed Web of Science ®Google Scholar
• Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–1470.
   PubMed Web of Science ®Google Scholar
• Katsarava Z, Buse DC, Manack AN, et al. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86–92.
   PubMed Web of Science ®Google Scholar
• Olesen J. Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders, Asbtracts. Cephalalgia. 2018;38(1):1–211.
   Web of Science ®Google Scholar
• Bigal ME, Serrano D, Reed M, et al. Chronic migraine in the population Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71(8):559–566.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–1168.
   PubMed Web of Science ®Google Scholar
• Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011;51(7):1058–1077.
   PubMed Web of Science ®Google Scholar
• Lipton RB. Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology. 2009;72(5, Suppl 1):S3–S7.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006;46(9):1334–1343.
   PubMed Web of Science ®Google Scholar
• Buse D, Manack A, Serrano D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81(4):428–432.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Silberstein SD. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache. 2015;55:103–122.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018;19(1):38.
   PubMed Web of Science ®Google Scholar
• Yamane K. [Progression from episodic migraine to chronic migraine]. Rinsho Shinkeigaku. 2014;54(12):997–999.
   PubMedGoogle Scholar
• Buse DC, Greisman JD, Baigi K, et al. Migraine progression: a systematic review. Headache. 2019;59(3):306–338.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Fanning KM, Buse DC, et al. Migraine progression in subgroups of migraine based on comorbidities: results of the CaMEO study. Neurology. 2019;93(24):e2224–e2236.
   PubMed Web of Science ®Google Scholar
• Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40(5):503–516.
   PubMed Web of Science ®Google Scholar
• Foster S, Chen C-C, Ding Y, et al., editors. Characteristics of patients with episodic and chronic migraine based on monthly headache days reported in a real-world electronic medical records database. San Francisco (CA): American Headache Society; 2018.
   Google Scholar
• Etemad LR, Yang W, Globe D, et al. Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. J Manag Care Pharm. 2005;11(2):137–144.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Romano PS, Roos LL, Jollis JG. Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–1079.
   PubMed Web of Science ®Google Scholar
• Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930–945.
   PubMed Web of Science ®Google Scholar
• statistics UBol. Consumer Price Index seasonally adjusted medical table Washington, DC. 2018; [cited 2018 Oct 30]. Available from: https://data.bls.gov/cgi-bin/surveymost?cu.
   Google Scholar
• Castillo J, Muñoz P, Guitera V, et al. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999;39(3):190–196.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Aurilia C, Egeo G, et al. Hypertension as a risk factor for migraine chronification. Neurol Sci. 2010;31(Suppl 1):S41–S3.
   PubMed Web of Science ®Google Scholar
• Buse DC, Silberstein SD, Manack AN, et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960–1969.
   PubMed Web of Science ®Google Scholar
• Janoska M, Chorążka K, Domitrz I. Migraine frequency and its association with dyslipidemia in women. Neurol Neurochir Pol. 2015;49(2):95–98.
   PubMed Web of Science ®Google Scholar
• Smitherman TA, Penzien DB, Maizels M. Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep. 2008;12(3):224–229.
   PubMed Web of Science ®Google Scholar
• Zwart J-A, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. the Nord-Trøndelag Health Study. Eur J Neurol. 2003;10(2):147–152.
   PubMed Web of Science ®Google Scholar